The Lancet Gastroenterology & Hepatology in conversation with
Un podcast de The Lancet Group
84 Épisodes
-
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
Publié: 08/02/2023 -
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
Publié: 23/01/2023 -
Dan Turner on vedolizumab in children with IBD
Publié: 06/01/2023 -
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
Publié: 09/11/2022 -
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
Publié: 05/10/2022 -
Filip Knop on liraglutide for bile acid diarrhoea
Publié: 07/09/2022 -
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
Publié: 04/08/2022 -
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer
Publié: 06/07/2022 -
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
Publié: 14/06/2022 -
Juan Pablo Arab on NAFLD public health policies in the Americas
Publié: 09/05/2022 -
Sarah Blach on hepatitis C virus epidemiology
Publié: 06/04/2022 -
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection
Publié: 23/03/2022 -
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
Publié: 09/03/2022 -
Swati Patel on early-onset colorectal cancer
Publié: 09/02/2022 -
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands
Publié: 10/12/2021 -
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa
Publié: 11/11/2021 -
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Publié: 09/09/2021 -
Raymond Henderson on the economic burden of colorectal cancer
Publié: 12/08/2021 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Publié: 22/06/2021 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Publié: 03/06/2021
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
